Related Experiment Videos
Clinical features of familial Mediterranean fever: an Italian overview
R Manna1, C Cerquaglia, V Curigliano
1Department of Internal Medicine, Catholic University of Sacred Heart, Rome, Italy. rmanna@rm.unicatt.it
Abstract:
Familial Mediterranean Fever (FMF) is the most frequent periodic febrile syndrome among the autoinflammatory syndromes (AS), nowadays considered as innate immunity disorders, characterized by absence of autoantibodies and autoreactive T lymphocytes. FMF is a hereditary autosomal recessive disorder, characterized by recurrent, self-limiting episodes of short duration (mean 24e72 h) of fever and serositis. In FMF, periodic attacks show inter- and intra-individual variability in terms of frequency and severity. Usually, they are triggered by apparently innocuous stimuli and may be preceded by a prodromal period. The Mediterranean FeVer gene (MEFV) responsible gene maps on chromosome 16 (16p13) encoding the Pyrine/Marenostrin protein. The precise pathologic mechanism is still to be definitively elucidated; however a new macromolecular complex, called inflammasome, seems to play a major role in the control of inflammation and it might be involved in the pathogenesis of FMF. The most severe long-term complication is type AA amyloidosis, causing chronic renal failure. Two types of risk factors, genetic and non-genetic, have been identified for this complication. Currently, the only effective treatment of FMF is the colchicine. New drugs in a few colchicine resistant patients are under evaluation
Insights
Familial Mediterranean Fever (FMF) is an autoinflammatory disorder causing recurrent fever and inflammation. Early diagnosis and colchicine treatment are crucial to prevent complications like AA amyloidosis.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Familial Mediterranean Fever (FMF) is the most common autoinflammatory syndrome.
- It is an autosomal recessive disorder characterized by recurrent fever and serositis.
- FMF is linked to mutations in the MEFV gene, encoding the Pyrine/Marenostrin protein.
Purpose of the Study:
- To summarize the current understanding of Familial Mediterranean Fever (FMF).
- To highlight the pathogenesis, clinical manifestations, and complications of FMF.
- To discuss current and potential future treatments for FMF.
Main Methods:
- Review of existing literature on FMF.
- Analysis of the genetic basis and molecular mechanisms of FMF.
- Discussion of clinical presentation, diagnosis, and management strategies.
Main Results:
- FMF presents with variable episodes of fever, serositis, and inflammation.
- The inflammasome complex is implicated in FMF pathogenesis.
- AA amyloidosis leading to renal failure is a severe complication.
- Colchicine remains the primary treatment, with new drugs emerging for resistant cases.
Conclusions:
- FMF is a significant autoinflammatory disorder requiring prompt management.
- Understanding the role of the inflammasome is key to FMF pathogenesis.
- Effective treatment, primarily colchicine, is vital for preventing long-term complications such as amyloidosis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Toxidromes: Clinical Features
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: